Latex allergy;Alergia al látex

Farmacia Hospitalaria

Volumn 30, Issue 3, 2006, Pages 177-186

  Navarrete, Ma Antonia ^a,c   Salas, A ^a   Palacios, L ^a   Marin J F ^a   Quiralte, J ^a   Florido, J F ^b  

^a Ciudad de Jaén Hospital   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c NONE   (Spain)

Author keywords

Latex allergy; Latex and medications; Latex products; Latex fruit syndrome; Professional allergy

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ALPHA 1 ANTITRYPSIN; BETA1A INTERFERON; CHICKENPOX VACCINE; CILASTATIN PLUS IMIPENEM; CLARITHROMYCIN; CLOXACILLIN; DIPHTHERIA TETANUS VACCINE; DOBUTAMINE; ENOXAPARIN; ERYTHROMYCIN ETHYLSUCCINATE; ESMOLOL; FONDAPARINUX; HEPATITIS A VACCINE; IMMUNOMODULATING AGENT; INFLUENZA VACCINE; INTERFERON BETA SERINE; LEUPRORELIN; MENINGOCOCCUS VACCINE; MITOXANTRONE; NADROPARIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OCTREOTIDE; PNEUMOCOCCUS VACCINE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT HEPATITIS B VACCINE; SUMATRIPTAN SUCCINATE; UNINDEXED DRUG;

ALLERGY; ANAMNESIS; DANGEROUS GOODS; EXPOSURE VARIABLE; HOSPITAL; HUMAN; IMMUNOTHERAPY; MEDICAL LITERATURE; REVIEW; SECONDARY PREVENTION; SENSITIVITY ANALYSIS; SKIN TEST;

EID: 33747636597     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-6343(06)73969-1     Document Type: Review

References (24)

1. Florido JF, Navarro A, Conde M, Torres M, Adame E, en representación del Servicio Andaluz de Salud. Recomendaciones para la prevención y tratamiento de la alergia al látex. Sevilla, 2004: 5-30.
2. Sussman GL, Beezhold DH, Kurup VP. Allergens and natural rubber proteins. J Allergy Clin Immunol 2002; 110 (Supl. 2): 33-9.
3. Yip E, Cacioli P. The manufacture of gloves from natural rubber latex. J Allergy Clin Immunol 2002; 110 (Supl. 2): 3-14.
4. De la Hoz B. Estrategias para la prevención de la alergia al látex. En: Blanco C, Quirce S, editores. Alergia al látex. Barcelona; 2002. p. 213-42.
5. Quirce S, Olaguibel JM. Asma causada por latex. En: Sastre J, Quirce S, editores. Patología respiratoria alérgica ocupacional. Madrid; 2003. p. 187-205.
6. Wagner S, Breiteneder H. Hevea Brasiliensis latex allergens: current panel and clinical relevance. Int Arch Allergy Immunol 2005; 136: 90-7.
7. Blanco C. Latex-Fruit Syndrome. Current allergy and asthma reports 2003; 3 (Supl. 1): 45-53.
8. Jorro G, Braso JV. Alergia al látex. En: Brasó JV, Jorro G editores. Manual de alergia clínica. Barcelona; 2003. p. 533-42.
9. Saary MJ, Kanani A, Alghadeer H, Holness DL, Tarlo SM. Changes in rates of natural rubber latex sensitivity among dental school students and staff members after changes in latex gloves. J Allergy Clin Immunolgy 2002; 109 (Supl. 1): 131-5.
10. Poley GE, Slater JE. Latex allergy. J Allergy Clin Immunol 2000; 105 (Supl. 6): 1054-62.
11. Blanco C, Sánchez-García F, Torres-Galván MJ, Dumpiérrez AG, Almeida L, Figueroa J, et al. Genetic basis of the latex-fruit syndrome: association with HLA Class II alleles in a Spanish population. J Allergy Clin Immunol 2004; 114: 1070-6.
12. Muller B. Minimizin latex exposure and allergy. Postgrad Med 2003; 113: 91-7.
13. Jiménez I, González M, Navarro A, Borrás J, Montesinos A, Sansano A, et al. Medicamentos que contienen látex: una información necesaria en la guia farmacoterapéutica. Farm Hosp 2002; 26: 234-44.
14. Jorge V, Villamayor L, Mira MC, Rabell S, Martínez M, Herrero MJ, et al. Elaboración de una guía hospitalaria de especialidades farmacéuticas con contenido en látex. Aten Farm 2004; 6: 262-74.
15. Mahler V, Fisher S, Fuchs T, Ghannadan M, Valent P, Fartasch M, et al. Prevention of latex allergy by selection of low-allergen gloves. Clin Exp Allergy 2000; 30: 509-20.
16. Sastre J, Fernández-Nieto M, Rico P, Martín S, Barber D, Cuesta J, et al. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2003; 111 (Supl. 5): 985-94.
17. Shojaei AR, Haas DA. Local anesthetic cartridges and latex allergy: a literature review. J Can Dent Assoc 2002; 68: 622-6.
18. Hoffman RP. Latex hypersensitivity in a child with diabetes. Arch Pediatr Adolesc Med 2000; 154 (Supl. 3): 281-2.
19. Towse A, O'Brien M, Twarog FJ, Braimon J, Moses AC. Local reaction secondary to insulin injection: a potencial role for latex antigens in insulin vials and syringes. Diabetes Care 1995; 18 (Supl. 8): 1195-7.
20. Roest MA, Shaw S, Orton DI. Insulin-injection-site reactions associated with type I latex allergy. N Engl J Med 2003; 348 (Supl. 3): 265-6.
21. Ventura JM, Fernández EM, Alós M, Vila M, Bataller A. Selección de recursos farmacoterapéuticos para asegurar un entorno periquirúrgico exento de latex. Farm Hosp 2001; 25: 208-14.
22. Primeau MN, Adkinson NF Jr, Hamilton RG. Natural rubber pharmaceutical vial closures release latex allergens that produce skin reactions. J Allergy Clin Immunol 2001; 107 (Supl. 6): 958-62.
23. San Miguel R, Andújar M, Cuenca ML, De La Higuera S, De Ancos F. Látex en medicamentos inyectables: elaboración de una guía y de un botiquín de urgencia para pacientes alérgicos. Rev OFIL 2002; 12 (Supl. 3): 13-24.
24. Cullinan P, Brown R, Field A, Hourihanes J, Jones M, Kekwick R, et al. Latex allergy. A position paper of the British Society of Allergy and Clinical Immunology. Clin Exp Allergy 2003; 33: 1484-99.